Near-Infrared Light for Peripheral Venous Catheterization in Adults With Difficult Venous Access
Use of Near-Infrared Light in Peripheral Venous Catheterization in Adult Patients With Difficult Venous Access
2 other identifiers
interventional
200
0 countries
N/A
Brief Summary
The goal of this clinical trial is to learn whether near-infrared (NIR) light can help healthcare professionals place a peripheral intravenous catheter in adults with difficult venous access. The main question it aims to answer is: \- Does using NIR light make successful catheter placement on the first needle puncture more likely than the usual method of looking for and feeling the vein? Researchers will compare NIR light with the usual method of looking for and feeling the vein to see which method works better for placing the catheter on the first needle puncture. Participants will:
- Have their veins located using either NIR light or the usual method of looking for and feeling the vein.
- Have a peripheral intravenous catheter placed by a healthcare professional.
- Report their pain and satisfaction with the procedure. Researchers will also record how many needle punctures are needed, how long catheter placement takes, how long the catheter remains in place, why it is removed, and whether any complications occur.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 5, 2026
CompletedFirst Posted
Study publicly available on registry
October 9, 2026
CompletedStudy Start
First participant enrolled
November 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2027
Study Completion
Last participant's last visit for all outcomes
October 31, 2027
October 9, 2026
October 1, 2026
11 months
October 5, 2026
October 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Successful Peripheral Intravenous Catheterization on the First Venipuncture Attempt
Successful catheterization will be defined as venous blood return upon vein entry, advancement of the peripheral intravenous catheter without resistance, and, after tourniquet release, administration of 5-10 mL of saline or initiation of intravenous infusion without resistance, infiltration, or pain. Blood return after final catheter positioning will not be required. The outcome will be recorded as successful or unsuccessful on the first venipuncture attempt.
During the peripheral intravenous catheter insertion procedure
Study Arms (2)
Near-Infrared Light
EXPERIMENTALParticipants assigned to this arm will undergo peripheral intravenous catheterization after vein localization using near-infrared light. Catheter insertion will otherwise follow the standard procedure.
Conventional Vein Localization
ACTIVE COMPARATORParticipants assigned to this arm will undergo peripheral intravenous catheterization after vein localization using direct visualization and palpation of the vein, without technological assistance. Catheter insertion will otherwise follow the standard procedure.
Interventions
A near-infrared vein visualization device will be used to locate superficial veins for peripheral intravenous catheter insertion. The device uses near-infrared light to visualize the venous pattern and projects the resulting vein image onto the participant's skin in real time. The device will be used for vein localization before venipuncture and may remain in use during venipuncture and catheter insertion at the healthcare professional's discretion. Peripheral intravenous catheter insertion will otherwise follow the standard procedure.
ein localization will be performed using the conventional method of direct visualization and palpation of the vein, without the use of near-infrared or other vein visualization technology. Peripheral intravenous catheter insertion will then be performed according to the standard procedure.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or older who require intravenous treatment expected to last less than one week and that can be administered through a short peripheral intravenous catheter (PIVC) to be inserted in a participating hospital unit.
- A score of 4 or higher on the A-DIVA scale.
- Written informed consent to participate in the study
You may not qualify if:
- Patients with an existing peripherally inserted central catheter (PICC), centrally inserted central catheter (CICC), femorally inserted central catheter (FICC), implanted vascular access device (PICC-Port or intravenous port), or tunneled vascular access device.
- Patients requiring intravenous treatment that is not appropriate for administration through a short PIVC according to the RNAO vascular access guideline, including solutions with pH \<5 or \>9, osmolarity \>500 mOsm/L, vesicant medications, vasoactive drugs, or parenteral nutrition.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Raquel López Nietolead
- Gerencia Regional de Salud de Castilla y Leoncollaborator
Study Officials
- PRINCIPAL INVESTIGATOR
Raquel López Nieto
Complejo Asistencial de Zamora.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Nurse
Study Record Dates
First Submitted
October 5, 2026
First Posted
October 9, 2026
Study Start (Estimated)
November 1, 2026
Primary Completion (Estimated)
September 30, 2027
Study Completion (Estimated)
October 31, 2027
Last Updated
October 9, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared with other researchers because the informed consent and data protection plan approved for this study do not provide for sharing individual participant data beyond the research team and other legally authorized access. Study results will be disseminated in aggregate form.